With our TCD academic teaching hospitals (St James's, Tallaght & St Patrick's University Hospitals), the Health Service Executive (HSE) and our service users our vision is to improve evidence-based clinical care.

We are running a clinical trial of cognitive remediation therapy based on promising preliminary data that this can help people with schizophrenia to function better in daily life.

We coordinate the Dublin arm for a national clinical trial (headed by Dr Maeve Rooney from UCC) on the efficacy of Omega-3 in people at high risk of developing schizophrenia.

We are investigating the diagnostic importance of auto-antibodies in first episode psychosis. This prospective study, running in conjunction with local clinical services, will be completed in mid-2016.